Related references
Note: Only part of the references are listed.Poly(phosphoester)s: A New Platform for Degradable Polymers
Tobias Steinbach et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Protein Corona of Nanoparticles: Distinct Proteins Regulate the Cellular Uptake
Sandra Ritz et al.
BIOMACROMOLECULES (2015)
Tailoring the stealth properties of biocompatible polysaccharide nanocontainers
Biao Kang et al.
BIOMATERIALS (2015)
Protein modification and maintenance systems as biomarkers of ageing
Valerie Vanhooren et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2015)
Complementary analysis of the hard and soft protein corona: sample preparation critically effects corona composition
S. Winzen et al.
NANOSCALE (2015)
Hyperbranched Unsaturated Polyphosphates as a Protective Matrix for Long-Term Photon Upconversion in Air
Filippo Marsico et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Therapeutic Protein-Polymer Conjugates: Advancing Beyond PEGylation
Emma M. Pelegri-O'Day et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Clusterin: a key player in cancer chemoresistance and its inhibition
Tomas Koltai
ONCOTARGETS AND THERAPY (2014)
Water-Soluble Poly(phosphonate)s via Living Ring-Opening Polymerization
Tobias Steinbach et al.
ACS MACRO LETTERS (2014)
Protein corona formation around nanoparticles - from the past to the future
Pablo Del Pino et al.
MATERIALS HORIZONS (2014)
Surface Polyethylene Glycol Conformation Influences the Protein Corona of Polyethylene Glycol-Modified Single-Walled Carbon Nanotubes: Potential Implications on Biological Performance
Cristiano Sacchetti et al.
ACS NANO (2013)
Anti-polyethyleneglycol Antibody Response to PEGylated Substances
Tatsuhiro Ishida et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2013)
Nanocapsules with specific targeting and release properties using miniemulsion polymerization
Katharina Landfester et al.
EXPERT OPINION ON DRUG DELIVERY (2013)
Hypersensitivity to Polyethylene Glycols
Sapna Shah et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Time Evolution of Nanoparticle-Protein Corona in Human Plasma: Relevance for Targeted Drug Delivery
Ana Lilia Barran-Berdon et al.
LANGMUIR (2013)
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology
Stefan Tenzer et al.
NATURE NANOTECHNOLOGY (2013)
Minimal Self Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
Pia L. Rodriguez et al.
SCIENCE (2013)
Poly(ethylene oxide)-block-polyphosphester-based paclitaxel conjugates as a platform for ultra-high paclitaxel-loaded multifunctional nanoparticles
Shiyi Zhang et al.
CHEMICAL SCIENCE (2013)
PEGylated nanoparticles for biological and pharmaceutical applications
Hidenori Otsuka et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Suppressing Unspecific Cell Uptake for Targeted Delivery Using Hydroxyethyl Starch Nanocapsules
Grit Baier et al.
BIOMACROMOLECULES (2012)
Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment
Carl D. Walkey et al.
CHEMICAL SOCIETY REVIEWS (2012)
The journey of a drug-carrier in the body: An anatomo-physiological perspective
Nicolas Bertrand et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Protein-resistant polymer surfaces
A. Woerz et al.
JOURNAL OF MATERIALS CHEMISTRY (2012)
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
Carl D. Walkey et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Biomolecular coronas provide the biological identity of nanosized materials
Marco P. Monopoli et al.
NATURE NANOTECHNOLOGY (2012)
No Diagnostic Value of Plasma Clusterin in Alzheimer's Disease
Edina Silajdzic et al.
PLOS ONE (2012)
Recent advances in stealth coating of nanoparticle drug delivery systems
Zohreh Amoozgar et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2012)
Nanoparticle Size Is a Critical Physicochemical Determinant of the Human Blood Plasma Corona: A Comprehensive Quantitative Proteomic Analysis
Stefan Tenzer et al.
ACS NANO (2011)
FDA-approved poly(ethylene glycol)-protein conjugate drugs
Steevens N. S. Alconcel et al.
POLYMER CHEMISTRY (2011)
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy
Parag Aggarwal et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones
Anja Zensi et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Recent Progress in Polyphosphoesters: From Controlled Synthesis to Biomedical Applications
Yu-Cai Wang et al.
MACROMOLECULAR BIOSCIENCE (2009)
Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process
I. Hamada et al.
MOLECULAR IMMUNOLOGY (2008)
Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods:: 2-DE, CE and protein Lab-on-chip® system
Hyun Ryoung Kim et al.
ELECTROPHORESIS (2007)
Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain
Jorg Kreuter et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles
Tommy Cedervall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Clusterin in cerebrospinal fluid:: Analysis of carbohydrates and quantification of native and glycosylated forms
A. -M. Nilselid et al.
NEUROCHEMISTRY INTERNATIONAL (2006)
Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes
T Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Preparation of fluorescent carboxyl and amino functionalized polystyrene particles by miniemulsion polymerization as markers for cells
V Holzapfel et al.
MACROMOLECULAR CHEMISTRY AND PHYSICS (2005)
PEGylation, successful approach to drug delivery
FM Veronese et al.
DRUG DISCOVERY TODAY (2005)
Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting
TM Göppert et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Competitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cells
L Thiele et al.
BIOMATERIALS (2003)
Clusterin is an ATP-independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding-competent state
S Poon et al.
BIOCHEMISTRY (2000)
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG):: influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption
R Gref et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2000)
Nanoparticles with decreasing surface hydrophobicities:: influence on plasma protein adsorption
A Gessner et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2000)
Share Paper
